Wiesbaden, Germany

Uwe Heinelt

USPTO Granted Patents = 45 

 

 

Average Co-Inventor Count = 5.2

ph-index = 9

Forward Citations = 384(Granted Patents)


Location History:

  • Weisbaden, DE (2006 - 2014)
  • Wiesbaden, DE (1999 - 2015)
  • Frankfurt-am-Main, DE (2011 - 2024)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
Loading Chart...
45 patents (USPTO):Explore Patents

Title: Uwe Heinelt: Innovator in Cartilage Disorder Treatments

Introduction

Uwe Heinelt, based in Wiesbaden, Germany, is an accomplished inventor with a notable portfolio of 43 patents to his name. His contributions to the field of pharmaceuticals, particularly in the treatment of cartilage disorders, are significant and innovative.

Latest Patents

One of Heinelt's recent patents focuses on substituted pyrido[3,4-b]indoles, which are designed for the treatment of cartilage disorders. This invention relates to 8-aryl-substituted and 8-heteroaryl-substituted 9H-pyrido[3,4-b]indoles that promote chondrogenesis and enhance cartilage matrix synthesis. These compounds can be pivotal in treating joint diseases such as osteoarthritis, providing options for patients needing cartilage regeneration. Furthermore, the invention encompasses methods for synthesizing these compounds, their pharmaceutical applications, and the compositions that integrate them.

Career Highlights

Uwe Heinelt has made significant strides in his professional career through his associations with renowned companies. He has previously worked with Sanofi-Aventis Deutschland GmbH and Aventis Pharma Deutschland GmbH, where he enhanced his expertise in pharmaceutical development and contributed to numerous innovative projects.

Collaborations

Throughout his career, Heinelt has collaborated with esteemed colleagues in the industry, including Hans-Jochen Lang and Klaus Wirth. These partnerships have played a crucial role in driving his research and developments in the field of pharmaceuticals.

Conclusion

Uwe Heinelt's work continues to impact the medical community, particularly in treating cartilage disorders. His innovative mindset and dedication to research exemplify the spirit of invention, making him a key figure in the pharmaceutical industry. As advancements in this field persist, his contributions will undoubtedly influence future innovations in cartilage regeneration therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…